A recent study by the CDC revealed over 1,500 children under 2 faced serious health issues, with three fatalities, due to common cold medicines in 2004-2005.
The FDA is reevaluating the risks and benefits of these drugs, especially for children under 2.
Pediatricians petitioned to stop marketing cold remedies like Toddler's Dimetapp to kids under 6.
Concerns about the safety and efficacy of these medicines led to a voluntary recall by Johnson & Johnson.
The FDA is reviewing the use of cough and cold drugs for children, emphasizing caution and proper dosing to prevent overdoses.
